Department of Ophthalmology-Blanton Eye Institute

Medicine & Life Sciences

1. Eye 100%
2. Macular Degeneration 47%
3. Visual Acuity 45%
4. Macular Edema 36%
5. Ocular Vision 31%
6. Ranibizumab 28%
7. aflibercept 27%
8. Diabetic Retinopathy 26%
9. Ophthalmology 25%
10. Vitrectomy 20%
11. Optical Coherence Tomography 20%
12. Vascular Endothelial Growth Factor A 18%
13. Intravitreal Injections 18%
14. Optic Nerve 18%
15. Retinal Detachment 17%
16. Papilledema 17%
17. Endophthalmitis 16%
18. Space Flight 16%
19. Therapeutics 16%
20. Injections 15%
21. Fluorescein Angiography 15%
22. Retina 14%
23. Pseudotumor Cerebri 14%
24. Giant Cell Arteritis 14%
25. Optic Nerve Diseases 13%
26. Retinal Perforations 13%
27. Retinal Vein Occlusion 12%
28. Retinopathy of Prematurity 12%
29. Diplopia 12%
30. Uveal melanoma 12%
31. Ophthalmologists 11%
32. Lasers 11%
33. brolucizumab 10%
34. Ischemic Optic Neuropathy 10%
35. Retinoblastoma 10%
36. Geographic Atrophy 9%
37. Visual Fields 9%
38. Temazepam 9%
39. Neoplasms 9%
40. Safety 9%
41. Retinal Vessels 9%
42. Cataract 9%
43. Choroidal Neovascularization 9%
44. Ophthalmoplegia 8%
45. Light Coagulation 8%
46. Eye Diseases 8%
47. Optic Disk 8%
48. Bevacizumab 8%
49. Lenses 8%
50. Neuroimaging 8%
51. Retinitis 7%
52. Magnetic Resonance Imaging 7%
53. Biopsy 7%
54. Abducens Nerve Diseases 7%
55. Intraocular Lenses 6%
56. Astronauts 6%
57. Triamcinolone Acetonide 6%
58. Headache 6%
59. Randomized Controlled Trials 6%
60. Intraocular Pressure 6%
61. Orbit 6%
62. Optic Neuritis 6%
63. Oculomotor Nerve Diseases 6%
64. Health Care Outcome Assessment 6%
65. Membranes 6%
66. Melanoma 5%
67. Uveitis 5%
68. Blood Vessels 5%
69. Eyelids 5%
70. Light 5%
71. Angiography 5%
72. Cavernous Sinus 5%
73. Hemianopsia 5%
74. Photography 5%
75. Endothelial Growth Factors 5%
76. Intracranial Pressure 5%
77. Drug Therapy 5%
78. Eye Manifestations 5%
79. Adrenal Cortex Hormones 5%
80. Pupil 5%
81. Steroids 5%
82. Fluocinolone Acetonide 5%
83. Pupil Disorders 5%